On the grounds of the observed hypermetabolic state and weight loss in AD patients even when they are under HFD intake, we wondered how HFD challenge could affect BBB megalin deletion mouse model weight and glucose metabolism. The gene discussed is LRP2; the disease is Alzheimer disease.